Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2 - Oudard, S; Culine, S; Vano, Y (Eur J Cancer, 2015)
et al.